A Tale of Three Hormones: hcg, Progesterone and AMH

Similar documents
Intérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

A Tale of Three Hormones: hcg, Progesterone and AMH

% Oocyte Donation Pregnancyes (days 3)

Serum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles

Is it the seed or the soil? Arthur Leader, MD, FRCSC

No influence of the indication of freeze-all strategy on subsequent outcome to frozen-thawed embryo transfer cycle

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

Progesterone and clinical outcomes

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY

L2. Optimising IVF outcomes through increased number of oocytes... 03

How to make the best use of the natural cycle for frozen-thawed embryo transfer?

IVF Protocols: Hyper & Hypo-Responders, Implantation

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Sample size a Main finding b Main limitations

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

How to make the best use of the natural cycle for frozen-thawed embryo transfer?

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

President : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman ICOG. Founder Trustee Women s Empowerment Foundation

Raoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest

E.G. Papanikolaou 1,2,3, *, G. Pados 1,3, G. Grimbizis 1,3, E. Bili 1,3, L. Kyriazi 3, N.P. Polyzos 4,P.Humaidan 5,H.Tournaye 4,andB.

(1.,, ) (2.,,, )

Infertility Clinical Guideline

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

Poor & Hyper responders: what is the best approach?

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group

- Meta. : (rfsh); (ufsh); (IVF); : R711.6 : A : X(2015) : hmg( FSH LH) [ufsh, (ufsh-p) (ufsh-hp)] (rfsh) [1] 80, rfsh, 90, :

Freeze-All Policy: Is It Right for Everyone?

NGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam

2013 Sep.; 24(3):

(BMI)=18.0~24.9 kg/m 2 ;

Risk of premature luteinization in IVF cycles and its impact on clinical pregnancy rate

Late follicular progesterone to estradiol ratio is not influenced by protocols or gonadotropins used

INDICATIONS OF IVF/ICSI

The emergence of Personalized Medicine protocols for IVF.

Number of oocytes and live births in IVF

Fertility assessment and assisted conception

Effects of HCG and LH on ovarian stimulation. Are they bioequivalent?

Treatment of Poor Responders

In vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day of HCG injection: An RCT

STIMULATION AND OVULATION TRIGGERING

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

A rationale for timing of luteal support post GnRH agonist trigger. Address: IVF Unit, Elisha Hospital, 12 Yair Katz Street, Haifa, Israel,

Bei Xu, Ph.D., Zhou Li, Ph.D., Hanwang Zhang, Ph.D., Lei Jin, Ph.D., Yufeng Li, Ph.D., Jihui Ai, Ph.D., and Guijin Zhu, M.D.

Središnja medicinska knjižnica

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer

International Journal of Women s Health and Reproduction Sciences Vol. 6, No. 2, April 2018, ISSN

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization

Chen et al. Reproductive Biology and Endocrinology (2018) 16:36 /s z

Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Ovarian hyperstimulation syndrome (OHSS)

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

2015 Mar.; 26(1):

Relevance of LH activity supplementation

Spontaneous ovulation versus HCG triggering for timing natural-cycle frozen thawed embryo transfer: a randomized study

High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol

AOGS COMMENTARY SHAHAR KOL 1, ROY HOMBURG 2,3, BIRGIT ALSBJERG 4 & PETER HUMAIDAN 5. Abstract

MSOME I+II: A NEW CUT-OFF VALUE FOR MALE INFERTILITY AND EMBRYO DEVELOPMENT PREDICTION ON INTRACYTOPLASMIC SPERM INJECTION CYCLES

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

Estimating the net effect of progesterone elevation on the day of hcg on live birth rates after IVF: a cohort analysis of 3296 IVF cycles

Ivf day 6 estradiol level

What is the POSEIDON concept?

Disclosure. Robert Fischer Fertility Centre Hamburg Hamburg, Germany. Declared no potential conflict of interest.

Individualized treatment based on ovarian reserve markers

Best practices of ASRM and ESHRE

Highly purified hmg versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists a randomized study

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

A comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat

LOW RESPONDERS. Poor Ovarian Response, Por

Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Results and Discussion

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success

LH activity administration during the

The impact of HMG on follicular fluid hormone levels, embryo quality and IVF outcome

Ovarian stimulation and inflammation, not always friends! Marc-André Sirard DVM PhD, Canadian Research Chair in Reproduction Genomics

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis

Frozen-thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy

The old IVF patient: An evidence based approach. Stratis Kolibianakis MD MSc PhD

Patient Price List. t: e: w:

Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.

High Peak Estradiol Predicts Higher Miscarriage and Lower Live Birth Rates in High Responders Triggered with a GnRH Agonist in IVF/ICSI Cycles

Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques

Pediatrics, Obstetrics and Gynecology, University School of Medicine, Valencia University, Valencia, Spain

Abstract. Introduction. RBMOnline - Vol 17. No Reproductive BioMedicine Online; on web 17 July 2008

Transcription:

A Tale of Three Hormones: hcg, Progesterone and AMH

Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m

Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia, Spain

4 Introduction What we know What we don t know Clinical management Progesterone rise is associated with poor clinical outcomes Higher progesterone level is associated with a greater dose of FSH Is the relationship causal? What are the mechanisms involved? Is progesterone increase related to poorer outcome in all patients? Can we prevent the progesterone rise? What should we do if progesterone increases?

5 What we know What we don t know Clinical management Progesterone rise is associated with poor clinical outcomes Higher progesterone level is associated with a greater dose of FSH Is the relationship causal? What are the mechanisms involved? Is progesterone increase related to poorer outcome in all patients? Can we prevent the progesterone rise? What should we do if progesterone increases?

Mean ongoing pregnancy rate (%) Mean ongoing pregnancy rate (%) Progesterone elevation on the day of hcg is associated with lower pregnancy rates 6 Agonists (n=1117) 43.9 (32.6 55.9) Antagonists (n=2855) 1.5 ng/ml 5 1.5 ng/ml 5 4 37.7 (34.5 41.1) 39.7 (31.9 48.1) 22.7 21. (1.1 43.4)(8.3 43.3) 24.* (14.3 37.4) 4 3 27.9 (23.1 33.4) 27.9 (26.1 29.8) 32.4 (25.2 4.5) 17.8* (1.7 28.1) 2.4 (11.5 33.6) 3 2 2 6.8 (2.3 18.2) 1 1 p=.23 OR (95% CI):.51 (.31.84); p=.7 p=.22 OR (95% CI):.5 (.33.76); p=.9 1. 1.1 1.25 1.26 1.5 1.51 1.75 1.76 2. >2. Serum progesterone on day of hcg (ng/ml) Bosch E, et al. Hum Reprod 21;25:292 21 1. 1.1 1.25 1.26 1.5 1.51 1.75 1.76 2. >2. Serum progesterone on day of hcg (ng/ml) *p<.5 for comparison with previous progesterone level interval

Negative association between progesterone elevation and the probability of pregnancy 63 studies: 55,199 fresh IVF cycles Category Number of studies Odds ratio (95% CI)*.4.6 ng/ml 5 studies (n=1659).39 (.14 1.8).8 1.1 ng/ml 4 studies (n=16,34).79 (.67.95) 1.2 1.4 ng/ml 19 studies (n=5885).67 (.53.84) 1.5 1.75 ng/ml 26 studies (n=21,647).64 (.54.76) 1.9 3. ng/ml 12 studies (n=15,91).68 (.51.91) *Odds ratio compare women with progesterone elevation with those without progesterone elevation (defined as.8 ng/ml) Venetis CA, et al. Hum Reprod Update 213;19:433 457..5 1. 1.5 2. Probability of pregnancy 7

Progesterone level on the day of hcg is associated with lower pregnancy rates Parameter ROC curve p value End of menstruation until the day of hcg administration AUC FSH.58.164 AUC E 2.61.84 AUC progesterone.63.31 AUC LH.46.562 Day of hcg administration FSH.48.811 E 2.48.811 Progesterone.44.339 LH.48.827 Kyrou D, et al. Fertil Steril 211;96:884 888 8

Serum progesterone levels (ng/ml.day) Progesterone level on the day of hcg (ng/ml) Progesterone elevation is associated with a greater dose of FSH 2 15 N=12 Total dose r=.447 p<.5 4 3 N=432 Daily dose p<.1 1 2 5 1 1 2 3 4 Total FSH dose (IU) Filicori M, et al. Hum Reprod 22;17:29 215 5 75 15 225 3 375 45 525 6 Daily FSH dose (IU) Bosch E, et al. Hum Reprod 21;25:292 21 9

Serum progesterone on day of hcg (ng/ml) Serum progesterone on day of hcg (ng/ml) Progesterone elevation is correlated with a high ovarian response 5 4 Number of oocytes N=432 p<.1 N=432 5 4 Estradiol on day of hcg p<.1 3 3 2 2 1 1 5 1 15 2 25 3 Oocytes (n) 1 2 3 4 5 Estradiol (pg/ml) Bosch E, et al. Oral presentation at the 24th Annual Meeting of the European Society of Human Reproduction and Embryology 28 1

Progesterone (ng/ml) Timing of progesterone rise is associated with follicle number, FSH dose and LH level 3.5 GnRH agonist control with purified FSH 3. 2.5 2. 1.5 1..5 Normal range: day of LH peak 5 follicles, FSH dose, LH level FSH dose, LH level FSH dose, normal LH level Normal FSH dose, LH level Normal FSH dose, normal LH level 4 3 2 1 hcg Days prior to hcg trigger Adonakis G, et al. Fertil Steril 1998;69:45 453; Fleming R, Jenkins J. Reprod Biomed Online 21;21:446 449 11

12 What we know What we don t know Clinical management Progesterone rise is associated with poor clinical outcomes Higher progesterone level is associated with a greater dose of FSH Is the relationship causal? What are the mechanisms involved? Is progesterone increase related to poorer outcome in all patients? Can we prevent the progesterone rise? What should we do if progesterone increases?

13 Is progesterone rise a real cause of lower pregnancy rates? Egg Endometrium

Early rise of serum progesterone levels has no detrimental effect on egg quality GnRH agonist egg donation cycles Characteristics <1.2 ng/ml (n=12) 1.2 ng/ml (n=12) Mature oocytes 16.9 ±.6* 19.4 ±.6* Fertilisation (%) 69.2 ± 2.1 68.2 ± 1.9 *p<.5 Cleavage (%) 9.6 ± 2.4 89.7 ± 2.3 Fragmentation (%) 7.9 ±.6 8.1 ±.6 Blastocyst (%) 65.9 ± 13.3 65.7 ± 1.3 Embryos transferred 1.9 ±.2 2. ±.3 Embryos cryopreserved 1.4 ±.2 1.5 ±.2 Implantation (%) 26.6 24. Pregnancy (%) 54.4 55.7 Melo MA, et al. Hum Reprod 26;21:153 157 Miscarriage (%) 5/65 (7.5) 8/67 (12.1) 14

High progesterone levels significantly alter endometrial gene expression A large number of significantly differentially expressed probe sets between groups B and C A.9 ng/ml 28 A + B B 1 1.5 ng/ml 1388 14 819 C >1.5 ng/ml Day of oocyte retrieval 1.5 ng/ml >1.5 ng/ml N=47 N=12 Day of hcg (+7) Van Vaerenbergh I, et al. Reprod Biomed Online 211;22:263 271 Labarta E, et al. Hum Reprod 211;26:1813 1825 15

Ongoing pregnancy rate (%) High progesterone is an independent risk factor for lower pregnancy rates Progesterone 1.5 ng/ml Progesterone >1.5 ng/ml Age Body mass index Serum estradiol levels Total gonadotrophin dose 5 5 5 5 4 4 4 4 3 3 3 3 2 2 2 2 1 1 1 1 <3 31 35 36 4 >4 <25 25 29.9 3 <1 1 1999 2 2999 3 <15 15 3 >3 Age (years) Body mass index (kg/m 2 ) Serum estradiol levels (pg/ml) Total gonadotrophin dose (IU) N=432 Bosch E, et al. Hum Reprod 21;25:292 21 16

Ongoing pregnancy rate (%) High progesterone has a detrimental effect on pregnancy rates, irrespective of ovarian response Progesterone 1.5 ng/ml Progesterone >1.5 ng/ml 5 4 3 N=432 * * * * 2 1 Bosch E, et al. Hum Reprod 21;25:292 21 1 5 6 1 11 15 16 2 >21 Number of oocytes *p<.5 17

Ongoing pregnancy rate (%) High responders are not affected by high progesterone levels 6 Progesterone 1.5 ng/ml 18.2 Progesterone >1.5 ng/ml 43.2 N=195 Power=19.3% 5 4 29.9 35.8 34.5 18.8 1. 38.9 23.7 39.2 3 2 1 1 5 oocyte 6 9 oocytes 1 13 oocytes 14 18 oocytes >18 oocytes Griesinger G, et al. Fertil Steril 213;1:1622 1628 Bosch E. Fertil Steril 213;11:e3 e4 18

Ongoing pregnancy (%) Ongoing pregnancy (%) High responders are not affected by high progesterone levels Progesterone 4 nmol/l Progesterone >4 nmol/l 5 HP-hMG (n=374) 5 rfshβ (n=375) 4 4 3 3 2 2 1 1 7 8 14 15 7 8 14 15 Oocytes retrieved Oocytes retrieved Devroey P, et al. Fertil Steril 212;97:561 571 19

Higher detrimental threshold of progesterone for high responders Studies or subgroups of studies analysing fresh IVF cycles performed in high responders or PCOS patients Category Number of studies Odds ratio (95% CI).8 1.1 ng/ml 1 study (n=34) 1.17 (.69 1.97) 1.2 1.4 ng/ml 4 studies (n=369) 1.9 (.65 1.85) 1.5 1.75 ng/ml 1 study (n=224) 1.1 (.56 2.17) 1.9 3. ng/ml 1 study (n=223).65 (.52.82) *Odds ratio compare women with progesterone elevation with those without progesterone elevation (defined as.8 ng/ml) Venetis CA, et al. Hum Reprod Update 213;19:433 457. 1. 2. 3. Probability of pregnancy 2

Ongoing pregnancy rate (%) Serum progesterone (ng/ml) Higher detrimental threshold of progesterone for high responders 5 High responders (n=223) Odds ratio (95% CI) 45 4 2.5 2.25 2.5 2 2.25.56 (.33.96)*.47 (.26.85)*.67 (.41 1.11) 35 1.75 2.8 (.49 1.29) 3 25 2 1.5 1.75 1.25 1.5 1 1.25.77 (.49 1.22).69 (.43 1.12) 1.15 (.7 1.9) Xu B, et al. Fertil Steril 212;97:1321 1327 Serum progesterone level (ng/ml)..5 1. 1.5 2. Probability of pregnancy *p<.5 for comparison with the progesterone level <1 ng/ml High ovarian response was defined as 2 oocytes retrieved

Implantation rate (%) Higher detrimental threshold of progesterone for high responders 5 4 3 2 * N=285 * High responders were defined as: Estradiol 3 pg/ml or >2 oocytes retrieved 1 <.5.51.7.71 1. 1.1 1.4 1.41 1.8 >1.81 Progesterone (ng/ml) Requena A, et al. Submitted to Reprod Biol Endocrinol *p<.5 22

Lower detrimental threshold of progesterone for low responders Studies or subgroups of studies analysing fresh IVF cycles performed in poor responders Category Number of studies Odds ratio (95% CI)*.8 1.1 ng/ml 1 study (n=285).14 (.3.61) 1.2 1.4 ng/ml studies 1.5 1.75 ng/ml 2 studies (n=1132).45 (.27.77) 1.9 3. ng/ml studies *Odds ratio compare women with progesterone elevation with those without progesterone elevation (defined as.8 ng/ml) Venetis CA, et al. Hum Reprod Update 213;19:433 457. 1. 2. Probability of pregnancy 23

24 What we know What we don t know Clinical management Progesterone rise is associated with poor clinical outcomes Higher progesterone level is associated with a greater dose of FSH Is the relationship causal? What are the mechanisms involved? Is progesterone increase related to poorer outcome in all patients? Can we prevent the progesterone rise? What should we do if progesterone increases?

Variable progesterone measurements with automated immunoassay analyzers N=189 Patton PE, et al. Fertil Steril 214;11:1629 1636 25

High progesterone levels are associated with high rfsh dose Study Andersen, et al. 26 1 Bosch, et al. 28 2 Devroey, et al. 212 3 *p.1 Protocol daily dose Long agonist 225 IU Antagonist 225 IU Antagonist 15 IU Number of oocytes Serum progesterone on day of hcg (ng/ml) HP-hMG rfsh HP-hMG rfsh 1. ± 5.4 11.8 ± 5.7*.82 ±.41 1.1 ±.53* 11.3. ± 6. 14.4 ± 8.1*.73 ±.42.99 ±.48* 9.1 ± 5.2 1.7 ± 5.8*.97 ± 1.1.97 ± 1.4 1. Andersen AN, et al. Hum Reprod 26;21:3217 3227 2. Bosch E, et al. Hum Reprod 28;23:2346 2351 3. Devroey P, et al. Fertil Steril 212;97:561 571 26

Progesterone per follicle volume unit (ml) Progesterone per follicle volume unit (ml) LH activity offsets the rise of progesterone induced by FSH Progesterone contribution to circulation per follicle volume unit (ml) hmg (n=3133) FSH (n=4718) 1. 1. 5. 5... Unpublished data 75 1 15 225 >225 hmg daily dose 75 1 15 225 >225 FSH daily dose p<.1 27

Different progesterone thresholds may apply when using different gonadotrophins MEGASET MERIT Platteau P, et al. Poster presentation at the 3th Annual Meeting of the European Society of Human Reproduction and Embryology 214 28

Proportion of patients (%) Blastocyst culture does not overcome the negative impact of high progesterone Pregnancy rates in patients with or without progesterone elevation on day of hcg after day 5 embryo transfer 6 5 4 3 5. p=.29 33.3 p=.45 45.1 3. Progesterone <1.5 ng/ml (n=144) Progesterone 1.5 ng/ml (n=6) 2 1 Clinical pregnancy rate Ongoing pregnancy rate Corti L, et al. Eur J Obstet Gynecol Reprod Biol 213;171:73 77 29

No impact of progesterone rise in frozen thawed cycles Frozen thawed ET cycles Category Number of studies Odds ratio (95% CI)*.8 1.1 ng/ml 3 studies (n=62) 1.3 (.79 1.34) 1.2 1.4 ng/ml 2 studies (n=74).83 (.62 1.11) 1.5 1.75 ng/ml 6 studies (n=274) 1.13 (.97 1.32) 1.9 2.5 ng/ml 5 studies (n=163) 1.3 (.84 1.27) *Odds ratio compare women with progesterone elevation with those without progesterone elevation (defined as.8 ng/ml) Venetis CA, et al. Hum Reprod Update 213;19:433 457. 1. 2. Probability of pregnancy 3

Pregnancy rate (%) Progesterone levels should be monitored even for frozen thawed embryo transfer in natural cycles 5 4 3 2 Clinical pregnancy rate Ongoing pregnancy rate Clinical and ongoing pregnancy rates of subjects with no progesterone rise, or 1 day, 2 days, and 3 days of progesterone elevation 1 No progesterone rise 1 day 2 days 3 days Lee VC, et al. Fertil Steril 214;11:1288 1293 31

Conclusion: What the evidence suggests Progesterone rise causes lower pregnancy rates due to endometrial receptivity impairment All patients can be affected, although different threshold levels should be considered depending on ovarian response and gonadotrophin choice Each clinic should set applicable threshold based on their population, treatment protocol and assay used Progesterone elevation may be reduced by avoiding the use of high doses of rfsh or adding hcg driven LH bioactivity Freezing all embryos and transfer in a subsequent artificial endometrial preparation cycle is recommended in case of progesterone rise in a fresh cycle 32